T-Cell Fuel Source, Chemotherapy Exposure Reduce Potential to Develop CAR-T Therapy – OncLive
OncLive |
T–Cell Fuel Source, Chemotherapy Exposure Reduce Potential to Develop CAR-T Therapy
OncLive Both prior chemotherapy and a dependence on glycolysis appear to reduce the potential to develop T cells into chimeric antigen-receptor (CAR) T-cell therapy. Oxygen consumption rate (OCR) analysis revealed a poor spare respiratory capacity (SRC) in the … |
